Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease

Mayuko Chikamatsu, Hiroshi Watanabe, Yuhi Shintani, Ryota Murata, Masako Miyahisa, Ayano Nishinoiri, Tadashi Imafuku, Mei Takano, Nanaka Arimura, Koh‐ichi Yamada,

Journal of Controlled Release · 2023 · 27 citations · 48 references

DOIFull text

Open access

Concepts

References

48